Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial (Q34745045)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial |
scientific article |
Statements
1 reference
Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial (English)
1 reference
R E Ratner
1 reference
J Rosenstock
1 reference
G Boka
1 reference
DRI6012 Study Investigators
1 reference
1 September 2010
1 reference
1 reference
27
1 reference
9
1 reference
1024-1032
1 reference
Identifiers
1 reference
1 reference
1 reference